Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - a double blind placebo controlled study

Inflammation Research ◽

10.1007/pl00000240 ◽

2001 ◽

Vol 50 (12) ◽

pp. 598-601 ◽

Author(s):

H. Valleala ◽

K. Laitinen ◽

L. Pylkkänen ◽

Y.T. Konttinen ◽

C. Friman

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Biochemical Response ◽

Controlled Study ◽

Single Infusion ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

SAT0145 Efficacy and Safety of Sirukumab in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of A Randomized, Double-Blind, Placebo-Controlled Study: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3741 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 717.1-717

Author(s):

T. Takeuchi ◽

C. Thorne ◽

G. Karpouzas ◽

S. Sheng ◽

W. Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Treatment ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Treatment Results ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

OP0024 Safety and efficacy of SBI-087 in subjects with active rheumatoid arthritis in a phase 2 randomized, double-blind, placebo-controlled study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.1707 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 60.3-61

Author(s):

N. Damjanov ◽

M. Tlustochowicz ◽

J. Aelion ◽

A. Dimic ◽

M. Greenwald ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D)

Value in Health ◽

10.1016/j.jval.2016.09.1074 ◽

2016 ◽

Vol 19 (7) ◽

pp. A531 ◽

Author(s):

T Takeuchi ◽

C Thorne ◽

G Karpouzas ◽

S Sheng ◽

W Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy

SpringerPlus ◽

10.1186/s40064-015-0895-9 ◽

2015 ◽

Vol 4 (1) ◽

Author(s):

Kathryn Hobbs ◽

Atul Deodhar ◽

Brian Wang ◽

Bojena Bitman ◽

Joyce Nussbaum ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Dmard Therapy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164186.624873 ◽

2009 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

ADDING LOW-DOSE CYCLOSPORIN A TO PARENTERAL GOLD THERAPY IN RHEUMATOID ARTHRITIS: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

Rheumatology ◽

10.1093/rheumatology/35.11.1142 ◽

1995 ◽

Vol 35 (11) ◽

pp. 1142-1149 ◽

Author(s):

G. BENDEX ◽

A. BJELLE

Keyword(s):

Rheumatoid Arthritis ◽

Cyclosporin A ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Gold Therapy ◽

Double Blind Placebo

Download Full-text

Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study

Inflammation Research ◽

10.1007/s00011-019-01218-y ◽

2019 ◽

Vol 68 (4) ◽

pp. 261-274 ◽

Author(s):

David L. Boyle ◽

Samuel E. DePrimo ◽

Cesar Calderon ◽

Dion Chen ◽

Paul J. Dunford ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Receptor Antagonist ◽

Mechanism Of Action ◽

Active Rheumatoid Arthritis ◽

Phase 2 ◽

Histamine H4 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

H4 Receptor ◽

Download Full-text

AB0471 Efficacy and Tolerability of A Homeopathic Medication Incena in Patients with Rheumatoid Arthritis (Randomized, Double-Blind, Placebo-Controlled Study)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2889 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 963.3-964

Author(s):

O. Iaremenko ◽

G. Mykytenko ◽

K. Iaremenko ◽

I. Matiyaschuk ◽

O. Ivashkivsky

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial

Trials ◽

10.1186/s13063-018-2849-3 ◽

2018 ◽

Vol 19 (1) ◽

Author(s):

Seunghoon Lee ◽

Yeeun Cho ◽

Jihye Kim ◽

Jung Won Kang ◽

Ga Young Yoon ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Herbal Medicine ◽

Study Protocol ◽

Active Rheumatoid Arthritis ◽

Pilot Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text